Drugs Xagena
Eli Lilly and Boehringer Ingelheim have received marketing authorization from the European Commission for Linagliptin 5 mg film-coated tablets ( Trajenta ) for the treatment of adults with type 2 diab ...
European Commission has granted marketing authorization to Jentadueto, which combines the DPP-4 inhibitor, Linagliptin and Metformin in a single tablet. Linagliptin and Metformin hydrochloride is a ne ...
